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Abstract
Autophagy plays diverse roles in Ras-related tumorigenesis. H-rasval12 induces autophagy through multiple signal-
ing pathways including Raf-1/ERK pathway, and various ERK downstream molecules of autophagy have been re-
ported. In this study, Bcl-2/adenovirus E1B 19-kDa–interacting protein 3 (BNIP3) is identified as a downstream
transducer of the Ras/Raf/ERK signaling pathway to induce autophagy. BNIP3 was upregulated by H-rasval12 at
the transcriptional level to compete with Beclin 1 for binding with Bcl-2. H-rasval12–induced autophagy suppresses
cell proliferation demonstrated both in vitro and in vivo by expression of ectopic BNIP3, Atg5, or interference RNA
of BNIP3 (siBNIP3) and Atg5 (shAtg5) using mouse NIH3T3 and embryo fibroblast cells. H-rasval12 induces different
autophagic responses depending on the duration of Ras overexpression. After a short time (48 hours) of Ras over-
expression, autophagy inhibits cell proliferation. In contrast, a longer time (2 weeks) of Ras overexpression, cell
proliferation was enhanced by autophagy. Furthermore, overexpression of mutant Ras, BNIP3, and LC3-II was
detected in bladder cancer T24 cells and the tumor parts of 75% of bladder cancer specimens indicating a positive
correlation between autophagy and tumorigenesis. Taken together, our mouse model demonstrates a balance
between BNIP3-mediated autophagy and H-rasval12–induced tumor formation and reveals that H-rasval12 induces
autophagy in a BNIP3-dependent manner, and the threshold of autophagy plays a decisive role in H-rasval12–induced
tumorigenesis. Our findings combined with others’ reports suggest a new therapeutic strategy against Ras-related
tumorigenesis by negative or positive regulation of autophagic activity, which is determined by the level of autophagy
and tumor progression stages.
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Introduction
Autophagy is a cellular stress–adaptive process in which double-membrane
structures called autophagosomes engulf cytosolic organelles and proteins,
fuse with lysosomes, and degrade them to provide energy to the cell [1,2].
This whole process is known as autophagic flux [3]. The autophagosome
contains the microtubule-associated protein light chain 3 (LC3), which is
the human homolog of Atg8 in yeast. It is found as LC3-I in the cytosol,
and as LC3-II (the lipidative derivate of LC3-I) on autophagosomal
membranes. Within the autophagosome and lysosomal structures, there
is also the polyubiquitin-binding protein p62/SQSTM1 (also named
sequestosome 1 [SQSTM1]), which yields protein bodies that can also
reside free in the cytosol and nucleus. During the autophagic flux, p62
recruits LC3 to form a complex that is transported to the autophagosomes
and subsequently degraded in an organelle created by the fusion of
autophagosomes and lysosomes called autophagolysosome [4]. Inhibiting
this fusion leads to accumulation of the LC3 and p62 proteins [5].
Autophagy can be activated by various stimuli including hypoxia
during tumor formation [6]. Furthermore, autophagy spatially and
temporally regulates tumor development by suppressing tumor growth
through regulating cell proliferation at the early stages of tumorigenesis
[7]. At later stages, cancer cells in the central area of the tumor mass are
poorly vascularized and undergo autophagy to overcome low-nutrient
conditions [8]. However, the underlying mechanisms by which diverse
types of stresses induce autophagy during cell transformation and
tumorigenesis remain controversial and require further studies.
Ras proto-oncogenes participate in cell transformation and initiation
of tumor formation with mutations of the Ras gene detected in approx-
imately 30% of human cancers [9–13]. It is known that H-rasval12
induces autophagy in human colorectal cancer, breast cancer, cervical
cancer, and mesenchymal stem cells through the ERK signaling path-
way [14–16]. In contrast, it inhibits the autophagic process through
activation of the class I phosphoinositide 3-kinase (PI3K) signaling
pathway [17] suggesting dual roles of ras genes in the autophagic pro-
cess. It is also known that Ras upregulates the Atg5 gene and activates
the Rac1/MKK7/JNK signaling pathway to induce autophagy [18]. In
contrast, recently, Ras upregulates Noxa (a BH3 only protein) through
the MEK/ERK pathway to promote autophagy by displacing members
of the Bcl-2 family from Beclin 1 [16,19]. Altogether, these studies
indicate that the mechanisms and signaling pathways of Ras-induced
autophagy are complicated and remain obscure.
BNIP3 (Bcl-2/adenovirus E1B 19-kDa–interacting protein 3) is
also known to induce autophagy [20–22], but its relationship with
Ras in the induction of autophagy has not been reported. BNIP3 is a
mitochondrial proapoptotic protein belonging to the Bcl-2 family. It
contains a Bcl-2 homology 3 (BH3) domain and a COOH-terminal
transmembrane domain [23]. Its proapoptotic activity is distinct from
other members of the Bcl-2 family that it is upregulated by the tran-
scription factor hypoxia-inducible factor 1α, which is activated by Ras
through the MEK/ERK signaling pathway [24].
In summary, oncogenic Ras is able to trigger tumorigenesis, up-
regulate BNIP3, and induce autophagy. In this study, we clarified
the roles of Ras as well as BNIP3-induced autophagy in tumorigenesis
using mouse NIH3T3 and embryo fibroblast cells.
Materials and Methods
Cell Lines
The H-rasval12 transformant, 7-4 cell, was derived from mouse
NIH3T3 fibroblast. MEF-Atg5(+/+)-Rasval12 and MEF-Atg5(−/−)-
Rasval12 cells derived from wild-type mouse embryonic fibroblasts [MEF-
Atg5(+/+)] and Atg5 knockout cells [MEF-Atg5(−/−)] were estab-
lished in our laboratory. MEF-Atg5(+/+) and MEF-Atg5(−/−) cells
(simian virus 40 T antigen immortalized) are from Dr N. Mizushima
(Tokyo Medical and Dental University, Japan). MEF-Atg5(+/+)-Rasval12
and MEF-Atg5(−/−)-Rasval12 the same as 7-4 cell harbor an induc-
ible H-rasval12 oncogene. All the above cell lines were maintained in
Dulbecco modified Eagle medium (12100-061; GIBCO, Gaithersburg,
MD) with 10% fetal bovine serum (04-001-1A; Biological Industries,
Kibbutz Beit Haemek, Israel) and at 37°C in a 5% CO2 incubator [10].
Immunofluorescent Staining
Cells (1 × 105 per well) were seeded on a slide and cultured with
isopropyl-β-D-thiogalactopyranoside (IPTG, 5 mM, I9003; Sigma,
Missouri, MO) for 48 hours, then fixed in methanol for 20 minutes.
The slide was incubated for 30 minutes in 0.1% Triton X-100 in
phosphate-buffered saline. Anti-LC3 polyclonal antibody (AP1802a;
Abgent, San Diego, CA), anti–Beclin 1 polyclonal antibody (sc-11427;
Santa Cruz, Santa Cruz, CA) and anti–Bcl-2 monoclonal antibody
(sc-783; Santa Cruz) were added on the slide and left overnight at
4°C. The fluorescent change of the cells was investigated under either a
fluorescent microscope (DP 70; Olympus, Tokyo, Japan) or a confocal
microscope (FV-1000; Olympus).
Transmission Electron Microscopy
Cells after IPTG (5 mM) induction were fixed with 2.5% glutaral-
dehyde in 0.1 M cacodylate buffer containing 4% sucrose, 1 mM
MgCl2, and 1 mM CaCl2 and postfixed in 1% osmium tetroxide.
Cells were embedded with LRWhite (14380; Agar Scientific, Stansted,
UnitedKingdom) after dehydrationwith ethanol.Ultrathin sectionswere
stained with saturated uranyl acetate and lead citrate at room temperature
for 1 hour and investigated under a transmission electron microscope
(HITACHI-7000, Tokyo, Japan).
Promoter Activity Assay
After transfection of the BNIP3 (pGL3-BNIP3, 0.2 μg) or Ras activity
luciferase reporter plasmid (pY2-Luc; containing Ets binding element,
0.2 μg) [25], the cells (1 × 105 per well) cultured in triplicate in 12-well
plates were treated with IPTG and incubated at 37°C for various times.
The cells were lysed in 100 μl of lysis buffer (E194A; Promega, Madison,
WI). The lysate was assayed for both firefly and Renilla luciferase ac-
tivities using the Dual-Glo Luciferase Assay System following the
manufacturer’s instructions (E1960; Promega), and relative luciferase
unit was measured by a luminometer (EG&G Berthold, Wildbad,
Germany). Luciferase activity of the firefly luciferase was normalized
for equal transfection efficiency based on Renilla luciferase activity in
each lysate, which was used as the control. The primers used for con-
struction of various deletion mutants of pGL3-BNIP3 were as follows:
BNIP3 forward 5′-CCTAGCTAGCACCCTTCCAACTCTC-
TTCCCTCTC-3′
BNIP3 reverse 5′-CCCCAAGCTTGCGCTCTTCTCTCTC-
TCTCCAAAC-3′
Western Blot Analysis
The total protein from the cell lysate was collected from the cells
after various treatments. For Western blot analysis, a previously de-
scribed procedure was applied [26]. The following antibodies were
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used: monoclonal antibodies for β-actin (A5441; Sigma), LC3 (PM036;
MBL, Nagoya, Japan), Pan-Ras (OP22; Calbiochem, San Diego,
CA), Pan-Rasval12 (OP38; Calbiochem), p62 (PM045; MBL),
Beclin 1 (sc-11427; Santa Cruz), BNIP3 (ab38621 and ab10433 for
the detection of monomer and dimmer BNIP3, respectively; Abcam,
Cambridge, United Kingdom), Bcl-2 (sc-783; Santa Cruz), and Atg5
(ab54033; Abcam).
Flow Cytometry Analysis
Cell viability. Cells were stained with the propidium iodide (PI,
0.04 mg/ml) (P4170; Sigma) followed by flow cytometry analysis.
Cell cycle. Cells were fixed with 70% ethanol and stored at −20°C
overnight, followed by staining with cell cycle buffer (PI, 0.04 mg/ml,
0.1% Triton-X 100 and RNase) followed by flow cytometry analysis.
Cell Transfection and RNA Interference
Cells (2 × 105 per well) in a six-well plate were transfected with
4 μg of pFlag-BNIP3, pHA-Atg5 (a gift from Dr N. Mizushima),
pshRNA-Atg5 (Institute of Molecular Biology, Academia Sinica, Taipei,
Taiwan), small interfering RNA (siRNA)–negative control (12935-300;
Invitrogen, Boston, MA) or siRNA-BNIP3 ([RNA]-GCC CAG CAU
GAAUCUGGACGAAGUA; Invitrogen) by Lipofectamine 2000 fol-
lowing the manufacturer’s instructions (Invitrogen). The control vector
was pFlag-CMV2 (Invitrogen).
Immunoprecipitation
Cells were harvested in lysis buffer, and 1 mg of cellular protein was
incubated with specific antibodies at 4°C overnight. Protein G agarose
bead (50 μl; 17-0618-01;GEHealthcare, Amersham, Buckinghamshire,
United Kingdom) was mixed with the immunocomplexes and collected
after centrifugation by adding SDS-PAGE sample buffer and boiled for
10 minutes. Western blot analysis was conducted and followed by re-
action with anti–Bcl-2 or anti–Beclin 1 antibodies. Western blots were
incubated with ECL (WBKLS0500; Millipore, Billerica, MA) and
exposed it by BioSpectrum AC (101-206-009; UVP, Upland, CA).
MTT Assay
Cells (4 × 103 per well) in the 96-well plates received different
treatments for 24, 48, and 72 hours. MTT solution (M2128; Sigma)
(0.05 mg/ml in Dulbecco modified Eagle medium) was added to each
well at 37°C for 3 hours. The medium was removed, and 100 μl of
dimethylsulfoxide (D4540; Sigma) was added. Cell proliferation was
determined by measuring the cell lysate at the optical density of 540
nm wavelength using a 96-well multiscanner autoreader (MRX II;
Thermo Lab Systems, Franklin, MA).
BrdU Incorporation Assay
Cells (1 × 105 per well) were seeded in six-well trays and treated
with IPTG for 48 hours. The cells were grown in bromodeoxyuridine
(BrdU; 0.04 mg/ml; B5002; Sigma) containing medium for 30 minutes,
fixed in acidic ethanol at −20°C for 10 minutes, and then incubated in
2N HCl for 10 minutes. Anti-BrdU polyclonal antibody (RPN202; GE
Healthcare) at a dilution of 1:400 was added to the well overnight at
4°C. The primary antibody was detected by fluorescein isothiocyanate–
conjugated goat anti-mouse IgG under a fluorescent microscope
(DP 70; Olympus).
Mice and Tumors
Female, 6-week-old NOD/SCID mice were obtained from the
Laboratory Animal Center of National Cheng Kung University. The
animals were maintained in a pathogen-free facility under isothermal
conditions with regular photoperiods. The experimental protocol
adhered to the regulation of the Animal Protection Act of Taiwan
and was approved by the Laboratory Animal Care and Use Committee
of the university. Six-week-old female NOD/SCID mice were injected
subcutaneously with 5 × 105 cells in 100 μl of phosphate-buffered
saline. Tumor volume was measured according to the formula: V =
0.52 × a2 × b (a indicating the smallest superficial diameter; b, the
largest superficial diameter) [27].
Immunohistochemical Staining
Slides of paraffin sections treated with polyclonal anti-LC3 (AP1802a;
Abgent) or monoclonal anti-Ki67 antibody (no. RM9106; Thermo
Scientific, Santa Clara, CA) were processed as described elsewhere
[28]. Briefly, the slides were labeled with biotin-linked secondary anti-
body followed by streptavidin (K3461; Dako Cytomation, Carpinteria,
CA) treatment for 10 minutes at room temperature. The slides were
treated with AEC solution for 10 minutes at room temperature and
then counterstained with 10% hematoxylin (3000-2; Muto Pure
Chemicals Co, Ltd, Tokyo, Japan) and mounted by glycerol gelatin
(GG1; Sigma).
Tumor Tissues
Samples were obtained from four patients diagnosed with bladder
cancers from Department of Urology, Chia-Yi Christian Hospital,
Chia-Yi, Taiwan. Informed consent was obtained from the patients
with approval by the institutional review board. Specimens were
obtained immediately after surgery and stored at −80°C. The frozen
tissue was extracted and homogenized in lysis buffer (the same buffer
used for cell lysis). After sonication for 20 minutes, samples were
centrifuged at 15,000 rpm for 20 minutes and heated at 100°C for
10 minutes. The RNA was extracted using a single-step method with
TRIzol reagent (15596-026; Invitrogen). For reverse transcription–
polymerase chain reaction (RT-PCR), first-stand complementary
DNA was synthesized 1 μg of total RNA with an oligo-dT primer
and the Molony murine leukemia virus reverse transcriptase (M1701;
Promega). The sequences of PCR primers were as follows:
BNIP3 forward 5′-GCATGAGTCTGGACGGAGTAG-3′
BNIP3 reverse 5′-CCGACTTGACCAATCCCATA-3′
LC3 forward 5′-CCACACCCAAAGTCCTCACT-3′
LC3 reverse 5′-CACTGCTGCTTTCCGTAACA-3′
β-actin forward 5′-TGGAATCCTGTGGCATCCATGAAAC-3′
β-actin reverse 5′-TAAAACGCAGCTCAGTAACAGTCCG-3′
The PCR protocol was conducted with the BNIP3 and LC3 pri-
mers at 94°C for 30 seconds, 60°C for 1 minute, and 72°C for 1 minute
(30 cycles), followed by 72°C for 10 minutes. The PCR protocol was
performed with the β-actin primer at 94°C for 30 seconds, 55°C for
30 seconds, and 72°C for 1 minute (25 cycles), followed by 72°C for
10 minutes.
Statistical Analysis
All data are presented as the mean ± SD. Differences between the ex-
perimental and control groups were analyzed by Student’s t test. P < .05
was considered statically significant: *P < .05, **P < .01, and ***P < .001.
Neoplasia Vol. 13, No. 12, 2011 H-ras Activates BNIP3 to Induce Autophagy Wu et al. 1173
Results
H-rasval12 Induces a Dynamic, Multistep Autophagic Process
We previously established various NIH3T3 stable cell lines har-
boring the inducible H-rasval12 oncogene under the regulation of a
lac-inducible system (designated 7-4 and 2-12) and IPTG has been
used to induce H-rasval12 overexpression. We also demonstrated that
H-rasval12 induces the transformation of NIH3T3 cells [9,26]. The
expression of LC3-II, a marker of autophagosomes, was gradually in-
creased from 24 to 48 hours and declined at 72 hours after IPTG
induction in 7-4 cells (Figure 1A) but not in the parental NIH3T3
cells (Figure W1A). The protein expression levels of another two
autophagy-related genes, namely, p62 and Beclin 1, were also increased
by H-rasval12 either at 24 or at 48 hours after IPTG induction (Fig-
ure 1A). These autophagic phenomena were also detected in another
inducible H-rasval12 clone 2-12 cells (data not shown). The double-
membrane vesicles with engulfed organelles (autophagosomes, Fig-
ure W1Ba) as well as the single-membrane vesicles with or without
organelles (autophagolysosome-like, Figure W1Bb) were detected in
7-4 but not in parental NIH3T3 cells at 48 and 60 hours after IPTG
induction under the transmission electron microscope (Figure W1B).
Our data suggest that H-rasval12 overexpression triggers autophagy.
Figure 1. BNIP3 regulates H-rasval12–induced autophagy. (A) The 7-4 cells were treated with IPTG for different periods. Total protein
extracts and the expression levels of Ras, BNIP3, LC3, p62, and Beclin-1 were evaluated by Western blot analysis using specific anti-
bodies. β-Actin was used as an internal control. (B) The 7-4 cells in the presence of IPTG were cotransfected with BNIP3 reporter plasmid
pGL3-BNIP3 together with various DN gene plasmids (DN Ras, DN Raf, DN ERK, and DN Ral) and treated with MEK inhibitor (PD98059)
and PI3K inhibitor (LY294002) for 24 hours after transfection. The BNIP3 promoter activity of each group was measured by the Dual-Glo
luciferase assay system. NT indicates the cells without any treatment. This experiment was conducted in triplicate and repeated at least
three times. (C) The 7-4 cells were transfected with BNIP3 siRNA (200 mM) and RNAi-negative control (200 mM) for 48 hours by
Lipofectamine 2000. The expression levels of BNIP3, LC3, and Ras protein were measured by Western blot analysis. (D) The 7-4 cells were
transfected with BNIP3 siRNA (200 mM) and RNAi-negative control (200 mM) for 48 hours, and LC3 puncta were investigated under a
confocal fluorescent microscope with anti-LC3 antibody and detected by fluorescein isothiocyanate–conjugated goat anti-rabbit IgG. NT
indicates the cells without any treatment. Cells containing 30 or more green LC3 puncta were defined as autophagic cells. Thirty cells were
evaluated by field, and three fields were counted. Error bars represent SD. *P < .05, **P < .01, or ***P < .001. Student’s t test.
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To further clarify that H-rasval12 induced autophagic flux and
caused the degradation of LC3-II and p62 at 72 hours after induction,
we used chloroquine (CQ), a blocker of autophagosome and lysosome
fusion, was used.Without CQ treatment, 7-4 cells showed very low level
of LC3-II expression at 72 hours after IPTG induction (Figures 1A and
W2A, lane 2) or without IPTG induction (Figure W2A, lane 1). When
the cells at 48 hours after IPTG induction were treated with CQ for
another 24 hours, evident accumulation of LC3-II and p62 protein
was detected (Figure W2A, lane 3), indicating that an autophagic flux
was induced. To confirm that H-rasval12 overexpression indeed induced
the autophagic flux, a tandem fluorescent-tagged LC3 (mRFP-GFP) re-
porter plasmid (ptfLC3) was transfected into 7-4 cells. The mRFP-LC3
is resistant to acidic conditions and continues to expression both before
and after fusion with lysosomes, but GFP expression was quenched
because of acidic conditions in the lysosome. Collectively, in the cell,
yellow-colored LC3 puncta represent the steady-state autophagosome
formation and red coloring represents the autophagy progression from
autophagosome to autolysosome, a sign of autophagic flux [29]. Our
data show that abundant red fluorescence (RFP) was detected at 72 hours
after IPTG induction compared with the cells without induction
(Figure W2B, NT vs IPTG). Furthermore, under the condition of
IPTG induction, yellow fluorescence became predominant in the cells
when CQ was added at 48 hours after induction to block the fusion of
autophagosome and lysosome (Figure W2B, IPTG vs IPTG + CQ).
Altogether, our Western blot analysis and fluorescent image data dem-
onstrate that H-rasval12 overexpression per se induces an autophagic flux
in NIH3T3 cells.
BNIP3 and Raf-1/ERK Signaling Pathway Are Required
for H-rasval12–Induced Autophagy
That H-rasval12 upregulates BNIP3 gene expression has been re-
ported by a microarray analysis [30]. BNIP3 protein expression, both
of monomer and dimmer, were gradually induced by H-rasval12 24 to
72 hours after IPTG induction (Figure 1A, monomer and Figure W3).
To clarify how H-rasval12 oncogene regulates BNIP3 expression, a
BNIP3 luciferase promoter plasmid (pGL3-BNIP3) was constructed
and transiently transfected into 7-4 cells. The BNIP3 promoter activity
was induced about two-folds when IPTG treatment for 48 hours com-
pared with 0 hour of treatment (FigureW4). The plasmid pY2-Luc con-
taining multiple Ets binding elements in the promoter was used as an
indicator of Ras activation [25] (Figure W4). It indicates that H-rasval12
upregulates BNIP3 at the transcriptional level. Further study showed that
the dominant-negative (DN) plasmids of Ras (DN-Ras), Raf-1 (DN-
Raf ), ERK (DN-ERK), and the MEK inhibitor PD98059 significantly
suppressed BNIP3 promoter activity (P < .05). In contrast, DNRalGDS
(DN-Ral) and the PI3K inhibitor LY294002 had no effect on BNIP3
promoter activity (Figure 1B). In summary, H-rasval12 upregulates BNIP3
at transcriptional level through the Raf-1/ERK signaling pathway.
Activation of the Raf-1/ERK pathway by H-rasval12 overexpression
and induction of autophagy was confirmed by the pharmaceutical
inhibitor U0126 (an inhibitor of MEK1 and MEK2), which suppressed
the phosphorylation level of ERK (p-ERK1/2) and decreased the expres-
sion level of LC3-II in a dosage-dependent manner (Figure W5A). It is
consistent with some reports that H-rasval12 induces autophagy through
ERK pathway [14,15]. Furthermore, LC3-II expression was almost un-
detectable in the 7-4 derivatives Ras-1 cells (containing H-rasval12 and
DN rasAsn17 plasmids) and Raf-M cells (H-rasval12 and DN raf-14B
plasmids) [10] under H-rasval12 overexpression conditions at 24 and
48 hours after induction (Figure W5B). It is indicated that H-rasval12
induces autophagy through the Raf-1/ERK signaling pathway. To
clarify whether BNIP3 participates in H-rasval12–induced autophagy
through the Raf-1/ERK signaling pathway, siRNA of BNIP3 was used.
LC3-II expression and LC3 puncta were decreased when H-rasval12–
induced BNIP3 was suppressed by BNIP3 siRNA (Figure 1, C and
1D). These data indicate that H-rasval12 induces autophagy in a
BNIP3-dependent manner. Altogether, H-rasval12 activated BNIP3
through the Raf-1/ERK signaling pathway. Both BNIP3 and the
Raf-1/ERK are required for H-rasval12–induced autophagic machinery.
H-rasval12–Induced BNIP3 Triggers the Release of Beclin 1
from the Beclin 1–Bcl-2 Complex
It is known that BNIP3 induces autophagy under hypoxic condi-
tions by competing with Beclin 1 for Bcl-2 [31,32]. To clarify whether
H-rasval12–induced autophagy also works through the same mecha-
nism, the relationship among BNIP3, Beclin 1, Bcl-2, and autophagy
was investigated. In the cells from 24 to 72 hours after IPTG induction,
the binding between Bcl-2 and Beclin 1 was dramatically decreased
at 48 hours demonstrated by immunoprecipitation (Figure 2A, fold
change from 1 to 0.6). At the same time point, colocalization of Beclin 1
and Bcl-2 (yellow dots) was decreased by immunofluorescent staining
(Figure 2B; NT vs IPTG). Our result show that the greatest loss of the
association between Bcl-2 and Beclin 1 was at 48 hours after IPTG
induction (Figure 2A). However, only part of Beclin 1 was displaced
by BNIP3, so the Beclin 1–Bcl-2 complex is still detectable but at a
reduced level at 72 hours under ras overexpression conditions. These
results suggest the increase of Beclin 1 release from the Beclin 1–Bcl-2
complex, whereas H-rasval12 was overexpressed. The relationship among
BNIP3, Bcl-2, and Beclin 1 was further confirmed either by over-
expression of ectopic BNIP3 (pFlag-BNIP3), which decreased colo-
calization of Beclin 1 and Bcl-2 (P < .01), or by silencing BNIP3
expression (siBNIP3), which increased the binding of Beclin 1 to
Bcl-2 (P < .05) (Figure W6). Taken together, our results suggest that
the binding between Beclin 1 and Bcl-2 is partially affected by BNIP3
competition. In summary, H-rasval12–induced BNIP3 expression trig-
gers autophagy possible through the increase of Beclin 1 release from
the Beclin 1–Bcl-2 complex.
Mutant Rasval12 Together with BNIP3 and LC3-II
Overexpression Are Detected in the Tumor Parts
of Clinical Bladder Cancer Specimens
To elucidate whether H-rasval12 upregulating BNIP3 and inducing
autophagy occur in human cancers, eight paired bladder cancer speci-
mens (normal part [N] and tumor [T]) were analyzed. Overexpression
of mutant Rasv, BNIP3, and LC3-II protein was detected in the tumor
parts of 75% bladder cancer specimens (6/8) (Figure 3A). Consistently,
the tumor specimens showing higher expression of BNIP3 and LC3
protein also expressed higher level of mRNA detected by RT PCR
(Figure 3B). This result is consistent with our above in vitro experi-
ments shown in Figure 1B and Figure W4 showing that Ras regulates
BNIP3 and autophagy at the transcriptional level. Altogether, mutant
Ras together with BNIP3 overexpression and autophagy activation
positively correlates with tumorigenesis of bladder cancer.
H-rasval12–Induced Autophagy Suppresses Cell Proliferation
and Causes Cell Cycle Arrest
To determine the effect of H-rasval12 induced autophagy on cell
fate, cell proliferation was evaluated after IPTG induction. Our data
show that under normal serum (10%) conditions, cell number was
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significantly decreased after H-rasval12 overexpression for 48 and 72 hours
(compared to the cells without IPTG induction) demonstrated by MTT
assay (Figure 4A). To clarify that the decreased cell number was caused
by increased cell death or decreased cell proliferation, flow cytometry
was used to evaluate cell viability, and BrdU incorporation was con-
ducted to determine cell proliferation. H-rasval12 overexpression does
not affect cell viability from 0 to 120 hours after IPTG induction as
demonstrated by flow cytometry analysis (Figure 4B). Prabhakaran
Figure 3. Mutant Rasval12 together with BNIP3 and LC3-II overexpression is detected in the tumor parts of the bladder cancer speci-
mens. (A) Immunoblot analysis of eight paired human bladder cancer specimens (tumor [T] and adjacent normal tissue [N]) for Pan-
Rasval12, LC3, and BNIP3 protein expression using specific antibodies. (B) The RNA of the above specimens was extracted for BNIP3
and LC3 expression by RT-PCR analysis. *Overexpression of Rasval12, BNIP3, and LC3-II of the protein (A) and RNA (B) comparing the tumor
versus normal tissue.
Figure 2. H-rasval12–induced BNIP3 triggers the release of Beclin 1 from Beclin 1–Bcl-2 complex. (A) The 7-4 cells after IPTG treatment for
24, 48, and 72 hours; the total protein extract was immunoprecipitated by anti–Beclin 1 antibodies and followed by immunoblot analysis
to evaluate the levels of Bcl-2 and Beclin 1. (B) With or without IPTG treatment of 7-4 cells for 48 hours, the decreased colocalization of
Beclin 1 (green) and Bcl-2 (red) was assessed under a fluorescence microscope. The white arrow points the colocalization of Bcl-2 and
Beclin 1 (yellow spots). The percentage of colocalization of Beclin 1 and Bcl-2 was quantified by counting the yellow dots in the cell.
Error bars represent SD. ***P < .001. Student’s t test.
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et al. [33] and Quinsay et al. [34] reported that BNIP3 induces cell
death together with loss of mitochondrial membrane potential (ΔΨm).
Differently, in our study, H-rasval12 overexpression did not decrease mi-
tochondrial membrane potential (ΔΨm) from 0 to 120 hours after induc-
tion (Figure W7). In summary, our data indicate that the increase of
BNIP3 does not induce cell death when H-rasval12 is overexpressed.
To further clarify cell proliferation was suppressed by H-rasval12
overexpression and H-rasval12–induced autophagy, BNIP3 and Atg5
(an essential gene for canonical autophagy) genes were manipulated
in 7-4 cells to control autophagic activity. Briefly, BNIP3 and Atg5
genes were overexpressed or silenced in 7-4 cells by pFlag-BNIP3 or
pHa-Atg5 to enhance autophagic activity and by siBNIP3 or shAtg5
RNA to suppress autophagic activity. Our data show that cell prolif-
eration was inversely correlated with autophagic activity demonstrated
by BrdU incorporation assay (Figure 4C ). In 7-4 cells, overexpressing
or silencing BNIP3 and Atg5 indeed affected autophagic activity as was
demonstrated by the LC3-II expression level and immunofluorescent
staining (Figures 1, C and D, and W8). Furthermore, cell cycle was
Figure 4. Autophagy suppresses H-rasval12–induced cell proliferation. (A) The 7-4 cells were treated with or without IPTG for 24, 48, and
72 hours. Cell growth was measured by MTT assay. (B) The 7-4 cells were treated with IPTG (5 mM) for 24, 48, 72, 96, and 120 hours and
followed by PI (0.04 mg/ml) labeling. Cell viability was evaluated by flow cytometry analysis, and cell population and quantitative data
were shown. (C) The 7-4 cells in the presence of IPTG were transfected with plasmids pFlag-BNIP3 (4 μg), pHA-Atg5 (4 μg), psh-Atg5
(4 μg), si-BNIP3 (200 mM), or pFlag-CMV2 (Vector) for 48 hours. Cell proliferation was determined by BrdU (0.02 g/ml) incorporation for
30 minutes. Anti-BrdU antibody and PI were used to label the treated cells for cell proliferation and nuclei, respectively. The merged
images showing green or yellow fluorescent cells represent proliferating cells, which were used to quantify the percentage of cell pro-
liferation. (D) The 7-4 cells were treated with IPTG for various times, and cell cycle was analyzed by PI staining followed by flow cytometry
analysis. (E) The MEF-Atg5(+/+)-Rasval12 and MEF-Atg5(−/−)-Rasval12 cells with or without IPTG treatment for 48 hours. Cell proliferation
was measured by BrdU staining. This experiment was conducted in triplicate and was repeated for three times. (F) The 7-4 cells received
two different treatments: 1) Short-time IPTG induction. The 7-4 cells were transfected with plasmid pHA-Atg5, psh-Atg5, or pHA-CMV
(vector) for 48 hours followed by IPTG induction for another 48 hours. 2) Long-time IPTG induction. The 7-4 cells were treated IPTG for
14 days and in the presence of IPTG followed by transfection with pHA-Atg5, psh-Atg5, or pHA-CMV plasmids for 48 hours. Cell proliferation
was measured by MTT assay. (G) The 7-4 cells received the same treatment as in F were analyzed by BrdU incorporation assay for cell
proliferation. Error bars represent SD. *P < .05, **P < .01, or ***P < .001. Student’s t test)
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analyzed by flow cytometry, whereas H-rasval12 was overexpressed and
the increased accumulation of cell population at the G0/G1 phase from
24 to 72 hours was detected (Figure 4D; 30%-53%), indicating cell
cycle arrest at the G1 phase. To further clarify cell proliferation sup-
pressed by H-rasval12 overexpression–induced autophagy, wild-type
mouse embryo fibroblast and Atg5 knockout MEF cell lines harboring
the inducible H-rasval12 were established. They are designated as MEF-
Atg5(+/+)-Rasval12 and MEF-Atg5(−/−)-Rasval12, respectively. Because
MEF-Atg5(−/−) is an autophagy-deficient cell line, the expression of
LC3-II induced by Ras and accompanied with Atg5 expression was
detected only in MEF-Atg5(+/+)-Rasval12 but not in MEF-Atg5(−/−)-
Rasval12 cells (Figure W9). H-rasval12 overexpression suppressed MEF-
Atg5(+/+)-Rasval12 cell proliferation but not MEF-Atg5(−/−)-Rasval12
cells (Figure 4E), further supporting the results mentioned above. In
summary, we propose that autophagy suppresses cell proliferation
through cell cycle arrest at the G1 phase under H-ras
val12 overexpression
conditions. To clarify the temporal role of H-rasval12–induced autophagy
in cell proliferation, pHa-Atg5 plasmid DNA and shAtg5 RNA were
used to enhance or suppress H-rasval12–induced autophagy, respec-
tively. Our data show that within 48 hours, overexpression of ectopic
Atg5 was followed by H-rasval12 overexpression (short-time rasval12
overexpression); autophagy plays a suppressive role in cell proliferation.
However, overexpression of ectopic Atg5 after constitutive Ras over-
expression in 7-4 cells for 2 weeks (long-time rasval12 overexpression),
autophagy switches to a promoting role in cell proliferation demonstrated
by MTT and BrdU analysis (Figure 4, F and G). The above event was
reversed when autophagy was suppressed by sh-Atg5. Altogether,
H-rasval12–induced autophagy temporally regulates cell proliferation.
H-rasval12–Related Tumorigenesis Is Suppressed When
Autophagy Activity Is Ectopically Induced
The data presented here demonstrate that increased autophagy fol-
lowed by H-rasval12 overexpression suppressed cell proliferation. To
further confirm whether autophagy plays a suppressive role in tumor
formation, MEF-Atg5(+/+)-Rasval12 and MEF-Atg5(−/−)-Rasval12
cells’ tumor formation in the mouse model was conducted. Our data
show that both mouse MEF-Atg5(+/+)-Rasval12 and MEF-Atg5(−/−)-
Rasval12 cells were able to form tumors when they were injected sub-
cutaneously (s.c.) into NOD/SCID mice. Comparing the tumor size
induced by these two cell lines regardless with or without IPTG induc-
tion, the tumor weight of the MEF-Atg5(−/−)-Rasval12 group in the
presence of IPTG is the largest (Figure 5A). Tumor size induced by
MEF-Atg5(−/−)-Rasval12 was decreased by the expression of HA-tagged
Atg5 protein (Figure 5B), indicating that autophagy plays a suppressive
role in H-rasval12–induced tumor formation.
Figure 4. (continued).
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We previously demonstrated that mouse NIH3T3 cells over-
expressing H-rasval12 form tumors in NOD/SCID and BALB/c mice
[9]. To further clarify the suppressive effect of autophagy on tumor-
igenesis, the NIH3T3 derivate 7-4 cell together with ectopic BNIP3
or BNIP3 siRNA for 48 hours followed by H-rasval12 overexpression was
s.c. injected into the mice. Similar to the results of MEF-Atg5(−/−)-
Rasval12 cells in Figure 5, A and B, overexpression of flag-tagged
BNIP3 in 7-4 cells decreased tumor weight and decreased BNIP3
Figure 5. Autophagy inhibits cell proliferation to suppress Ras-induced tumor formation. (A) The MEF-Atg5(+/+)-Rasval12 and MEF-
Atg5(−/−)-Rasval12 cells (5 × 105) with or without IPTG treatment were injected s.c. into SCID mice. The tumor weight was measured
at 14 days after IPTG induction. (B) The MEF-Atg5(−/−)-Rasval12 cells with or without IPTG treatment were transfected with HA-Atg5 (pHA-
Atg5; 4 μg) or vector (pHA-CMV) for 48 hours. The cells (5 × 105) were injected s.c. into SCID mice. Each group composed of three mice.
The tumor weight wasmeasured at 13 days after IPTG induction. (C) The 7-4 cells (1 × 106/well) after transfection of BNIP3 siRNA (200 mM),
pFlag-BNIP3, or vector control plasmid DNA (24 μg) for 48 hours in the presence of IPTG were injected into the left and right sides of each
mouse. Mice were fed with IPTG (12.5 mM) containing water for 15 days. (D) Protein extracted from the tumors of the killed mice was
analyzed by immunoblot analysis for Ras, LC3, and BNIP3 protein expression. There were four mice in each group. Left panel shows the
protein expression of each of the four treated mice; the right panel represents the average protein expression of four mice protein mixture.
(E) The sections from the tumors were labeled with rabbit-conjugated LC3 antibody for LC3 expression. The arrows point at the LC3
expressing cells. (F) Representative sections of the tumors were labeled with anti-Ki67 antibody to detect Ki67 expression. The arrows
point at the Ki67-positive cells. Error bars represent SD. *P < .05, **P < .01, or ***P < .001. Student’s t test.
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expression by siRNA-increased H-rasval12–related tumor formation
(Figure 5C ). The expression levels of BNIP3 and LC3-II were indeed
higher in tumors of 7-4 cells expressing the ectopic BNIP3 gene. Con-
versely, the expression levels of BNIP3 and LC3-II were low in the
tumors treated with BNIP3 siRNA (Figure 5D, left panel: the protein
expression of each of the four treated mice; right panel: the average
protein expression of four mice protein mixture). Furthermore, the
expression level of LC3 protein in tumor tissue detected by immuno-
histochemical staining (Figure 5E ) is consistent with the result
of Western blot analysis (Figure 5D). Our data demonstrate that
H-rasval12 induces autophagic activity and tumorigenesis simultaneously,
and overexpression of ectopic BNIP3 increases autophagic activity in
tumors. In contrast, silencing endogenous BNIP3 reduced autophagic
activity. In addition, Ras expression levels in all of the tumors were
similar (Figure 5D), suggesting that ras is required for tumor forma-
tion but is dispensable for the influence on tumor size through BNIP3
regulation of autophagic activity.
Autophagy has been shown to exert an inhibitory effect on tumor
formation through induction of cell death [5,16]. However, in our
inducible system, H-rasval12 BNIP3–induced autophagy did not
cause cell death before 48 hours, which was confirmed by autophagy
inducer rapamycin, overexpression of BNIP3, Atg5, or by suppres-
sion of autophagy with shAtg5 or siBNIP3 (Figure W10). To clarify
whether suppression of H-rasval12–induced tumor formation by
BNIP3-mediated autophagy is through inhibition of cell prolifera-
tion, Ki67 (an indicator of cell proliferation) was used to stain the
tumor sections collected from the above tumor formation experiment
(Figure 5F ). Our data show that tumor cell proliferation in the pres-
ence of IPTG was significantly increased when BNIP3 expression
was silenced by siRNA compared with the tumor cells overexpressing
ectopic BNIP3 or vector control (Figure 5F ). This result is consistent
with the above the data of our in vitro study, which showed that
H-rasval12–related autophagy inhibits cell proliferation (Figure 4C ).
Taken together, H-rasval12–induced tumor formation of the NIH3T3
cells in mice can be suppressed by BNIP3-induced autophagy through
inhibition of cell proliferation. In conclusion, H-rasval12 induces
BNIP3 overexpression, autophagy, and tumorigenesis simultaneously.
When BNIP3 expression is further boosted, induced autophagy plays
a suppressive role in regulating H-rasval12–related cell transformation
and tumorigenesis.
Discussion
In this study, we revealed that H-rasval12 oncogene upregulates
BNIP3 at the transcriptional level through the Raf-1/MEK/ERK
signaling pathway. Our finding that Raf-1/MEK/ERK is the major
signaling pathway for H-rasval12–induced autophagy (Figure W5) is
consistent with reports from the human mesenchymal stem cells and
HT-29 cells [14,15]. Byun et al. [18] reported that H-rasval12 in-
creases Atg5 expression and activates the Rac1/MKK7/JNK signaling
pathway to induce autophagic cell death. This indicates that H-rasval12
may use diverse signaling pathways to induce autophagy as well as
autophagic responses depending on the stimuli encountered and the cell
types. Furthermore, GAIP (a mammalian GTPase activating protein)
and NOXA (a BH3-only protein) are downstream mediators of the
MEK/ERK signaling pathway to induce autophagy in colon cancer
HT-29 cells and breast cancer MCF-7 cells, respectively [15,16]. Here,
we reveal that BNIP3 is another downstream molecule of the MEK/
ERK signaling pathway to induce autophagy in mouse fibroblast cells.
Consistent with the report of Elgendy et al. [16], we also detected that
H-rasval12 induces autophagic flux in vitro, as demonstrated by degra-
dation of LC3-II and p62 protein at the late stage of autophagic pro-
gression (Figure 1A; 72 hours) as well as the accumulation of LC3-II
and p62 after the treatment with CQ at 48 hours after IPTG induc-
tion (Figure W2, A and B).
During hematopoiesis, a stem cell factor binds the receptor, acti-
vates hypoxia-inducible factor 1α, and upregulates BNIP3 through
the Ras/MEK/ERK and PI3K signaling pathways [24]. Similarly,
H-rasval12 upregulates BNIP3 at a transcriptional level through the
Raf-1/MEK/ERK signaling pathway. BNIP3 overexpression induces
either apoptosis or autophagy in a cell type–specific manner [23].
Under the conditions of H-rasval12 overexpression, BNIP3 is upregu-
lated and autophagy is induced in mouse fibroblast cell lines (NIH3T3
and MEF). A similar event was also detected in human bladder cancer
T24 cells (which expresses the H-rasval12 oncogene). BNIP3, a member
of Bcl-2 family induced by hypoxia, competes with Beclin 1 for Bcl-2
binding, and Beclin 1 is released to induce autophagy [31,32,35].
Noxa, another Bcl-2 family member and a BH3-only protein, is also
upregulated by H-rasval12 and promotes autophagy by displacing
MCL1 (a Bcl-2 family member), from Beclin 1 [16,19]. Similarly, in
NIH3T3 cells, BNIP3 induced by H-rasval12 competes with Bcl-2 for
the binding with Beclin 1 (Figures 2, A and B, and W6). The inter-
action between Beclin 1 and Bcl-2 is decreased at 48 and 72 hours after
IPTG induction as compared with the control (fold change from 1 to
0.6). The greatest loss of the association between Bcl-2 and Beclin 1
was at 48 hours after IPTG induction (Figure 2A). BNIP3 competed
with Beclin 1 for binding with Bcl-2 under ras overexpression con-
ditions. Therefore, the binding between Beclin 1 and Bcl-2 was de-
creased. However, the Beclin 1–Bcl-2 complex is still detectable but
at a reduced level at 72 hours after IPTG induction, indicating that
only part of Beclin 1 was displaced by BNIP3. Furthermore, H-rasval12
overexpression also increases Beclin 1 expression (Figure 1A), which
also contributes to autophagy induction. In summary, H-rasval12–
induced BNIP3 expression triggers autophagic progression possibly
through the increase of Beclin 1 release from Beclin 1–Bcl-2 complex
as well as Beclin 1 expression. Furthermore, whether Ras-induced
BNIP3 competes with Beclin 1 on the endoplasmic reticulum or on
mitochondria requires further investigation. BNIP3 is a specific activa-
tor of mitochondrial autophagy (mitophagy) and the mitochondrial
membrane potential (ΔΨm) is decreased in mitophagy mediated by
BNIP3-LC3 interaction [21,22]. In this study, H-rasval12 overexpres-
sion did not decrease mitochondrial membrane potential in 7-4 cells
(Figure W7); however, the possibility that BNIP3 induces autophagy
through BNIP3-LC3 interaction cannot be excluded.
Oncogenic Ras activation without other oncogenic alterations
induces autophagy followed by cell death through suppression of the
mammalian target of rapamycin (mTOR) signaling pathway [36–
38]. However, in tumor cells, Ras-induced autophagy is required to
maintain energy balance and prevents cells from death. The reports
cited indicate that cell fate affected by Ras-induced autophagy remains
contradictory. In this study, Ras overexpression-induced autophagy
blocks cell proliferation both in vitro and in vivo using mouse fibroblast
cells. Denoyelle et al. [39] demonstrated that H-rasval12-induced senes-
cence is mediated by unfolded proteins associated with the endoplasmic
reticulum and is a critical step in tumor suppression. By contrast,
oncogenic K-ras escapes premature senescence during tumorigenesis
of primary pancreatic duct epithelial cells through up-regulation of
twist and suppression of p16INK4A [40]. Collectively, ras oncogene
induces or escapes cell proliferation and senescence depending on other
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oncogenic mutations, duration of Ras overexpression, cell types, and
microenvironments. In this study, cell death (Figure 4B), suppression
of mTOR signaling (Figure W11), and cell senescence (Figure W12)
were not detected when autophagy was induced by H-rasval12 in mouse
fibroblast cells. Briefly, Figure W11 shows that the phosphorylation of
both mTOR and p70S6K was increased, suggesting that mTOR/
p70S6K signaling pathway is not involved. Furthermore, Figure W12,
A and B, shows that no β-glactosidase–expressing cells as well as over-
expression of DCR2 protein (indicators of cell senescence) were detected.
Instead, H-rasval12–induced autophagy suppressed cell proliferation
(Figure 4C ) accompanied with cell cycle arrest at the G0/G1 phase
(Figure 4D). Similarly, tumor formation in mice was also suppressed
by ectopic expression of BNIP3 through inhibition of cell proliferation,
as demonstrated by Ki67 staining in tissue (Figure 5, C and F). In con-
clusion, our finding that H-rasval12–induced autophagy suppresses
tumor formation through suppression of cell proliferation without
causing cell death is different from other reports using different cell lines
[18,41,42]. H-rasval12–induced autophagy suppresses cell proliferation
possibly through cell cycle arrest at the G0/G1 phase. It is known that
autophagy may degrade the ubiquitinated proteins that bind LC3
through p62 [4]. Cell cycle–related protein cyclin D1 is ubiquitinated
and degraded by proteasomes during cell cycle progression [43]. So, it is
possible that the induced cell cycle arrest at the G0/G1 stage by Ras, as
well as the suppression of cell proliferation is mediated through the
degradation of cyclin D1 by autophagy.
The evidences claiming that autophagy plays either a suppressing or
a promoting role in tumorigenesis are accumulating [16,19,44–46].
Our data show that H-rasval12 simultaneously induces tumor for-
mation and autophagic activity; however, under such conditions,
the level of autophagy seems not sufficient to suppress tumorigenesis,
indicating that Ras plays a dominant role during tumor formation.
By overexpressing ectopic BNIP3 in H-rasval12–overexpressing cells,
autophagic activity was further boosted and the dominance of H-rasval12–
induced colony formation (data not shown) as well as tumor formation
was subverted (Figure 5C ). Negative regulation of H-rasval12–induced
tumor formation by autophagy was further confirmed by using MEF-
Atg5(+/+)-Rasval12 and MEF-Atg5(−/−)-Rasval12 cells (Figure 5, A and
B). In conclusion, tumorigenesis induced by H-rasval12 is negatively
regulated by autophagy when its level is over or under a specific thresh-
old (referred as the “Goldilocks principle”) [16,19]. However, in
immortalized baby mouse kidney cells or pancreatic ductal adenocarci-
noma cells with Ras overexpression, autophagy was induced to promote
tumorigenesis. Similarly, in the human bladder cancer cell line T24,
autophagy also plays a promoting role in T24 cell proliferation demon-
strated by BrdU analysis using siRNA of BNIP3 or Atg5 (FigureW13).
In eight bladder cancer patients analyzed, 75% of the specimens
showed high expression of mutant Rasval12, BNIP3, and LC3-II
proteins as well as the mRNA in the tumor part (Figure 3, A and B).
Collectively, this indicates that autophagy plays a promoting role in
bladder cancer tumorigenesis, which is consistent with three recent
reports [45–47]. Further study is required to clarify the underlying
mechanism of the autophagic responses to the cells overexpressing
the Ras oncogene and affecting tumorigenesis.
We have shown that ras overexpression–induced autophagy blocks
cell proliferation both in vitro and in vivo using mouse fibroblast cell
lines (MEF and NIH3T3). Interestingly, when Ras overexpression
in these cells was continued for 2 weeks, the effect of autophagy on
cell proliferation switches from suppression to promotion (Figure 4,
F and G ), indicating a temporal regulation of autophagy on cell fate.
However, the underlying mechanism of the temporal regulation of
autophagy on cell fate currently is unclear and requires further investi-
gation. In conclusion, autophagy, a gatekeeper of cell transformation,
plays dual roles in Ras-overexpressed cells [45,46].
Altogether, we demonstrate a balance between BNIP3-mediated
autophagy and H-rasval12–induced tumorigenesis. We also reveal that
BNIP3-mediated autophagy suppresses H-rasval12–induced cell transfor-
mation and tumorigenesis in vivo through inhibition of cell proliferation.
The threshold of autophagy as well as the temporal regulation of auto-
phagy by H-rasval12 is involved in H-rasval12–induced tumorigenesis.
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Figure W1. H-rasval12 induces autophagosome formation. (A) The NIH3T3 cells were treated with IPTG for various times and protein
was extracted, and the expression levels of Ras, BNIP3, LC3, p62, and Beclin-1 were evaluated by immunoblot analysis using specific
antibodies. β-Actin was used as an internal control. (B) NIH3T3 and 7-4 cells after IPTG treatment for 48 and 60 hours were sectioned
and investigated under transmission electron microscopy. The higher magnification is shown in a and b. The arrowhead points the
autophagosome, and the arrow points the autophagolysosome-like vesicles.
Figure W2. H-rasval12 induces the autophagic flux. (A) The 7-4 cells were treated with lysosome inhibitor CQ (50 μM) at 48 hours after
IPTG induction for 24 hours. The protein extracted was assessed for the expression levels of LC3 and p62 by immunoblot analysis. (B) The
7-4 cells were transfected with ptfLC3 plasmid. After transfection for 24 hours, cells were treated with IPTG for another 48 hours. The
7-4 cells were treated with CQ (50 μM) at 48 hours after IPTG induction for 24 hours and investigated under a confocal microscope. White
arrow points the spot showing autophagosomes (red [RFP] and green [GFP]), yellow arrow points the spot showing autophagolysosomes
(red [RFP] only). Colocalization of mRFP and GFP puncta was quantified and shown as the percentage of the total number of mRFP puncta.
Twenty cells were counted in each view, and three views were investigated.
Figure W3. The expression levels of monomer and dimmer of
BNIP3 are increased under H-rasval12 overexpression conditions.
The 7-4 cells were treated with IPTG from 24 to 72 hours, and
protein was extracted and the expression levels of BNIP3, Ras,
and β-actin were evaluated by immunoblot analysis with specific
antibodies. The anti-BNIP3 antibody (ab10433) was from Abcam.
Figure W4. H-rasval12 induces BNIP3 promoter activity. The 7-4 cells
were transfected with plasmid pGL3-BNIP3 or pY2Luc (0.2 μg/each),
and the promoter activity at various times after IPTG treatment was
measured by luciferase activity assay. The pY2Luc is the reporter
plasmid for measuring Ras activity and was used as a positive con-
trol. The plasmid pGL3 was used as the vector control.
Figure W5. Ras induces autophagy through ERK pathway. (A) The 7-4 cells were treated with various dosages of U0126 in the presence
of IPTG. The expression levels of phosphorylated ERK (p-ERK) and LC3 protein were evaluated at 48 hours after treatment. α-Tubulin was
used as the internal control. (B) The 7-4 cell and its derivates Ras-1 (containing DN-ras) and Raf-M (containing DN–raf-1) were treated
with IPTG for 24, 48, and 72 hours. The protein was extracted for evaluation of LC3 and Ras expression by Western blot analysis. β-Actin
was used as an internal control.
Figure W6. BNIP3 competes with Beclin 1 to bind with Bcl-2. The 7-4 cells in the presence of IPTG were transfected with siRNA of
BNIP3, pFLAG-BNIP3, or pFlag-CMV2 (Vector) for 48 hours. Colocalization of Beclin 1 (green) and Bcl-2 (red) was assessed and quantified.
Figure W7. H-rasval12 overexpression does not decrease mitochon-
dria membrane potential in NIH3T3 cells. After IPTG treatment of
7-4 cells for 0, 24, 48, 72, 96, and 120 hours, DiOC6 (318426; Sigma)
dye that contains fluorescence (1 μM) was used to analyze mito-
chondria membrane potential by flow cytometry. The cell treated
with IPTG for 0 hour was used as the control.
Figure W8. BNIP3 and Atg5 were expressed or silenced in the
transected cells. The 7-4 cells were transfected with pFlag-BNIP3
plasmid DNA (4 μg), pHA-Atg5, psh-Atg5 (4 μg), or pFlag-CMV2
(Vector) for 48 hours. The expression levels of Flag-BNIP3, HA-
Atg5, LC3, and Atg5 were detected by Western blot analysis using
antibodies against Flag (no. 2368; Cell Signaling), anti-HA (H6908;
Sigma), LC3, and Atg5.
Figure W9. The inducible Ras system was established in MEF-Atg5(+/+) and MEF-Atg5(−/−) cell lines and ras induces autophagy in
MEF-Atg5(+/+) cells. MEF-Atg5(+/+) andMEF-Atg5(−/−) cells were transfected with plasmid pSVlacOras and placI, and H-ras–inducible
cell lines after G418 selection were established. These cell lines were treated with IPTG (5 mM) for 0, 24, 48, and 72 hours, and the
expression of Atg5, LC3, Ras, and β-actin was detected with specific antibodies and analyzed by immunoblot analysis. β-Actin was used
as an internal control.
Figure W10. H-rasval12–induced autophagy does not trigger cell
death. The 7-4 cells in the presence or absence of IPTGwere treated
with rapamycin (50 nM), pFlag-BNIP3 (4 μg), psh-Atg5 (4 μg), or si-
BNIP3 (200 mM) for 48 hours and then labeled with PI (0.04 mg/ml).
Cell viability was evaluated by flow cytometry analysis at 72 hours
after treatment.
Figure W11. The mTOR signaling pathway is activated by H-rasval12.
After IPTG treatment of 7-4 cells for 0, 24, 48, and 72 hours, the
expressions of mTOR signaling pathway–related proteins (mTOR,
p-mTOR, and its downstream protein p70S6K and p-p70S6K) were
evaluated using specific antibodies by Western blot analysis. The
following antibodies were used: mTOR (no. 2983; Cell Signaling),
p-mTOR (no. 2971; Cell Signaling), p70S6 kinase (no. 2708; Cell
Signaling), and p-p70S6 kinase (no. 9206; Cell Signaling). β-Actin
was used as an internal control.
Figure W12. H-rasval12 overexpression does not induce senes-
cence in NIH3T3 cells. (A) The 7-4 cells were treated with IPTG
for 72 hours, and senescence was detected by expression of
SA-β-galactosidase. α-Catulin expression in lung adenocarcinoma
cell line (A549) is knocked down by lentiviral expression of α-Catulin
shRNA, which is used as a senescence control cell line. (B) The
7-4 cells were treated with IPTG for various times, and protein
was extracted. The expression levels of decoy receptor 2 (DCR2),
a senescence marker, was detected by Western blot analysis.
Figure W13. H-rasval12 overexpression–induced autophagy suppresses cell proliferation in human bladder cancer cell line. T24 cells in
the presence of IPTG were transiently transfected with RNAi-negative control, si-Atg5, or si-BNIP3 (200 mM) for 48 hours. Cell prolifera-
tion was determined by BrdU (0.02 g/ml) incorporation for 30 minutes. Anti-BrdU antibody and PI were used to label the treated cells
for cell proliferation and nuclei, respectively. The expression levels of Atg5, BNIP3, and LC3 were detected with specific antibodies by
Western blot analysis.
